Intensive insulin therapy is promoted by health professionals and patients who believe that &dquo;normalizing&dquo; diabetic patients' blood glucose levels might prevent or delay the development of chronic complications. Teams of physicians, nurse educator/specialists, dietitians, social workers, psychologists, and others have worked closely with patients who have attended many hours of educational sessions to learn sophisticated self-management skills. This team approach has facilitated intensive therapy principles, making normoglycemia an extremely challenging but attainable goal. Pursuit of this goal has resulted in a dramatic shift in attitude toward the clinical management of many people with insulindependent diabetes mellitus.
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Intensive Insulin Therapy: Assessment and Application Intensive insulin therapy is promoted by health professionals and patients who believe that &dquo;normalizing&dquo; diabetic patients' blood glucose levels might prevent or delay the development of chronic complications. Teams of physicians, nurse educator/specialists, dietitians, social workers, psychologists, and others have worked closely with patients who have attended many hours of educational sessions to learn sophisticated self-management skills. This team approach has facilitated intensive therapy principles, making normoglycemia an extremely challenging but attainable goal. Pursuit of this goal has resulted in a dramatic shift in attitude toward the clinical management of many people with insulindependent diabetes mellitus.
Researchers, clinicians, and patients have now begun to critically assess the implications of &dquo;tight control.&dquo; Probably the most common question is whether the maintenance of normoglycemia is related to the prevention of microvascular and macrovascular complications. Another issue concerns the acute risks associated with tight control (ie, hypoglycemia) and their long-term impact. The disagreement over optimal methods of management may or may not be satisfied by longitudinal clinical trials designed to empirically assess the outcome of specified diabetes therapies. The Diabetes Control and Complications Trial (DCCT) is one such study; it should provide the answers to many vital questions related to intensive insulin therapy.
Regardless of the current controversies and research studies, the extensive interest of health professionals in intensive therapy warrants a comprehensive overview of state-of-theart management techniques. This prompted us to compile a series of review papers that emphasize the practical application of intensive insulin therapy. This series of papers will be presented in the next several issues of The Diabetes Educator. Multidisciplinary authors with extensive expertise in intensive therapy have contributed to the series. Several of the authors were among those who originally pioneered intensive insulin therapy; their names should be familiar because of their previous writings on this subject.
This series begins with a paper on continuous subcutaneous insulin infusion pump therapy written by Ruth Farkas-Hirsch, MS, RN, CDE, and Lucy Levandoski, PA-C. This paper will be of particular interest to those who are considering whether or not to implement a CSII program. The second paper in the series discusses the downside risks of intensive management, namely, hypoglycemia. Carolyn Havlin, RN, and Philip Cryer, MD, review the literature and present the opinion that patients must be taught reasonable respect for hypoglycemia, but not unreasonable fear of it.
In upcoming issues, other papers will consider nutritional and exercise guidelines; psychosocial aspects and common adjustment problems for various age groups; care and education of the pregnant diabetic patient; the importance of a multidisciplinary health care team; and other risks and complications. The series will conclude with an overview of the Diabetes Control and Complications Trial. Early feasibility study results and the overall purpose and goals of this complex study will be presented.
It has been a pleasure working with all of our expert authors. We are certain you will be professionally stimulated and challenged by these articles, and we solicit your response and discussion. such as the nutrition review in this issue, will appeal to health care professionals who are new to the field of diabetes education. Other papers will explore topics m greater depth and will be of interest to experienced diabetes educators. We thank ICI-Stuart Pharmaceuticals for sponsoring this series. We encourage AADE members to suggest topics to be con- 
